Cargando…
A brief performance evaluation and literature review of Abbott ID Now COVID-19 rapid molecular-based test
The qualitative ID Now COVID-19 assay combines claimed performance and ease of use that seem to position it as a reliable test for urgent patient management. However, the declared limit of detection (LOD) of 125 genome equivalents/mL is not confirmed by the published studies, which observed a range...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452348/ https://www.ncbi.nlm.nih.gov/pubmed/34555430 http://dx.doi.org/10.1016/j.jviromet.2021.114293 |